News

| Sharon Reingwirtz
December 21st, 2017

Gornitzky represents GEOC, a Chinese investment fund, in a USD 5 million venture financing round.

Gornitzky represented Shanghai GEOC Hengtong Investment Limited Partnership, a Chinese investment fund, and its affiliates in a USD 5 million Series B investment round in Vectorious Medical Technologies Ltd. in which they were the lead investors together with Broadview Ventures.

Vectorious Medical Technologies Ltd. is developing a minimally-invasive heart implant, which, together with a user-friendly external home-unit, provides easy-to-access daily medical data. The VectoriousTM system increases CHF patient quality of life by providing early, accurate physiological indication of cardiac decompensation. Patients enjoy ongoing, personalized care, physicians save lives and cut healthcare costs.

Shanghai GEOC Hengtong Investment Limited Partnership and its affiliates were represented by Timor Belan (Partner), Avi Meer, Ori Sheinkman (Labor), Oleg Omeli and Sharon Reingwirtz

October 24th, 2017

Gornitzky represents a Chinese investment fund in a USD 16 million Series B venture financing round.

Gornitzky represented Shanghai GEOC Hengtong Investment Limited Partnership, a Chinese investment fund, and its affiliates, including Fortune China Limited, in a USD 16 million Series B investment round in S.D. Sight Diagnostics Ltd. in which they were the lead investors.

 

S.D. Sight Diagnostics specializes in utilizing advanced computer vision and machine learning technology in the field of blood diagnostics.

 

Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Limited were represented by Timor Belan (Partner) and Associates Avi Meer and Sharon Reingwirtz.